Last week, Dr Karla Soares-Weiser was appointed as Cochrane’s Chief Executive Officer.

Cochrane’s Governing Board is pleased to announce the appointment of Dr Karla Soares-Weiser as the organization’s new Chief Executive Officer.

For over 30 years, the Cochrane Collaboration has set the standard for systematic reviews in health research. Our reviews have saved and improved countless lives across the world, providing trustworthy evidence to inform health decisions at all levels, from international policymakers to individual patients.We now want to take evidence synthesis to the next level, creating a more dynamic, open and equitable system so that decision-makers always have the latest evidence at their fingertips.

A new tool to identify problematic trials is now available, enabling researchers to check whether studies are trustworthy before including them in systematic reviews. What is INSPECT-SR?The INSPECT-SR tool (INveStigating ProblEmatic Clinical Trials in Systematic Reviews) was created by an international group of researchers to address the risks posed by untrustworthy randomized controlled trials (RCTs).

A systematic review for the Royal College of AnaesthetistsWith the UK’s National Health Service facing critical workforce shortages, the Royal College of Anaesthetists (RCoA) needed to better understand the role that non-physician providers of anaesthesia, such as anaesthesia associates (AAs), could play in delivering safe, effective care.

Updated evidence shows that tailored exercise programs, vitamin D supplements and dairy-rich diets can help reduce falls in care homes.Falls remain one of the most serious health risks facing older people living in residential aged care around the world.

Results show no clear evidence of benefit for ketamine in chronic pain and identified an increased risk of adverse effects such as delusions, delirium, paranoia, nausea, and vomiting

Cochrane is piloting two evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas of global health: dengue prevention and neonatal mortality reduction.

Senior Research Integrity Editor, Lisa Bero As systematic reviewers, we synthesize the best available evidence to inform the decisions of the public, patients, clinicians, and policy makers. But what happens when the evidence is fatally flawed? Lisa Bero argues that systematic reviewers are uniquely positioned – and ethically obligated – to detect problematic studies and champion research integrity.

We are pleased to announce the launch of a new interactive learning module on rapid reviews, designed to support researchers and health decision-makers who need to produce high-quality evidence quickly and efficiently.